| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Special Articles |
Division of Endocrinology, Bnai-Zion Medical Center (T.R., G.D.), Haifa 31048; and Division of Radionuclear Medicine, Carmel Medical Center (S.B.-H.), Haifa 34362, Israel
Address all correspondence and requests for reprints to: Dr. Gabriel Dickstein, Division of Endocrinology, Bnai Zion Medical Center, P.O. Box 4940, Haifa 31048, Israel.
We report a case of a 17-cm cortisol-secreting adrenocortical carcinoma in which [123I]metaiodobenzylguanidine (MIBG) scan showed accumulation of the isotope in the area of the tumor. Catecholamine levels were normal, and no chromaffin cells were found in histological examination of the tumor. A literature review of previously described cases of false positive MIBG scans in the adrenal region is offered. We conclude that MIBG scans might not be as specific as previously thought in differentiating pheochromocytoma from adrenocortical carcinoma. They should be performed only when clinical suspicion and abnormalities in catecholamines advocate the need.
This article has been cited by other articles:
![]() |
Y Inoue, M Akahane, T Kitazawa, H Ijichi, S Obi, K Yoshikawa, K Ohtomo, and M Omata False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma Br. J. Radiol., June 1, 2002; 75(894): 548 - 551. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |